Invitrocue Limited (ASX: IVQ), a leading healthcare bio-analytic solutions provider, is pleased to announce the signing of a new technology development agreement with the Shanghai Institute of Biochemistry and Cell Biology (SIBCB), Chinese...
Read moreHeidelberg Pharma AG (FSE: WL6) announced today that it has received a milestone payment from its cooperation partner Link Health Co., Guangzhou, China. The transaction follows the approval of the Chinese National Medical Product Administration...
Read moreBio-Thera Solutions of Guangzhou has begun dosing rheumatoid arthritis patients in a global Phase III trial of its biosimilar to Genentech’s RoActemra®. Bio-Thera’s BAT1806 is one of four Bio-Thera candidates in Phase III trials. The...
Read moreChina’s leading mobile payment supplier, Wechat Pay, has teamed with Paris-based department Le BHV Marais, to help European businesses connect with growing Chinese tourists. WeChat Pay on Wednesday introduced a smart and sustainable...
Read moreLianluo Smart Limited (“Lianluo Smart” or the “Company”) (Nasdaq: LLIT), a China based professional smart service and products provider, today announced its wearable sleep diagnostic products and cloud-based service from...
Read moreBeijing-based Immunochina Pharmaceuticals today announced the closing of its $140 million RMB Series C financing (approximately $20.4 million in US Dollars). This financing will enable the company to expand its GMP-grade manufacturing...
Read moreShanghai’s I-Mab Biopharma announced that its novel CD73 antibody (TJD5), an immunotherapy, was cleared to start Phase I trials in the US. TJD5, the second I-Mab candidate to begin US clinical trials, will be tested in patients with...
Read moreThe U.S. Food and Drug Administration (FDA) approved South Korea’s Samsung Bioepis’ Ontruzant (trastuzumab-dttb), a biosimilar to Genentech’s Herceptin (trastuzumab). Samsung Bioepis is a joint venture between Samsung Biologics and Biogen. The...
Read moreAOTI Inc. announced today that it has entered into a major strategic relationship with a leading Chinese medical company, Nanning Xinzizhu Trading Co.,Ltd, for distribution of its patented Topical Wound Oxygen (TWO2) therapy wound healing...
Read moreiKang Healthcare, a private China healthcare chain, completed a $1.4 billion privatization backed by an Alibaba investment arm and Yunfeng Capital, a private equity firm co-founded by Alibaba’s Jack Ma and David Yu. The company, which seems...
Read moreCVS Health and Walmart said the world’s largest retailer would remain part of CVS’s network for commercial and Medicaid pharmacy customers. The deal broke a contract impasse CVS disclosed earlier this week. Financial terms of the new...
Read moreJanssen Pharmaceutical and Apple have teamed up to determine if a new app for the Apple Watch, which has a built-in electrocardiogram can improve the health of more than 30 million people with atrial fibrillation (AFib), a condition that can lead...
Read more
